Wei Xia

机构：University of Shanghai for Science and Technology · ORCID：0009-0008-4146-7738

发表论文 9 篇 · 总被引 25 次 · h-index 2

代表论文

• Boosting Sonodynamic/Gas/Chemo Therapy through Triple Inhibiting Multidrug Resistance Using Responsive Biodegradable Sulfide‐Vacancy‐Rich Nanosheets (2025 · Advanced Healthcare Materials · 被引 9)
• Silencing HEATR1 Rescues Cisplatin Resistance of Non-small Cell Lung Cancer by Inducing Ferroptosis via the p53/SAT1/ALOX15 Axis (2024 · Current Cancer Drug Targets · 被引 9)
• The endoplasmic reticulum stress-related genes and molecular typing predicts prognosis and reveals characterization of tumor immune microenvironment in lung squamous cell carcinoma (2024 · Discover Oncology · 被引 2)
• [Retracted] microRNA‑605 promotes cell proliferation, migration and invasion in non‑small cell lung cancer by directly targeting LATS2 (2022 · Experimental and Therapeutic Medicine · 被引 1)
• [Retracted] MicroRNA‑139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression (2022 · Oncology Letters · 被引 1)
• [Dongbai Tonglin Mixture for the treatment of chronic prostatitis]. (2024 · PubMed)